The Combined Treatment of Curcumin with Verapamil Ameliorates the Cardiovascular Pathology in a Williams–Beuren Syndrome Mouse Model
Open Access
- 7 February 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (4) , 3261
Abstract
Williams–Beuren syndrome (WBS) is a rare disorder caused by a recurrent microdeletion with hallmarks of cardiovascular manifestations, mainly supra-valvular aortic stenosis (SVAS). Unfortunately, there is currently no efficient treatment. We investigated the effect of chronic oral treatment with curcumin and verapamil on the cardiovascular phenotype of a murine model of WBS harbouring a similar deletion, CD (complete deletion) mice. We analysed systolic blood pressure in vivo and the histopathology of the ascending aorta and the left ventricular myocardium to determine the effects of treatments and their underlying mechanism. Molecular analysis showed significantly upregulated xanthine oxidoreductase (XOR) expression in the aorta and left ventricular myocardium of CD mice. This overexpression is concomitant with increased levels of nitrated proteins as a result of byproduct-mediated oxidative stress damage, indicating that XOR-generated oxidative stress impacts the pathophysiology of cardiovascular manifestations in WBS. Only the combined therapy of curcumin and verapamil resulted in a significant improvement of cardiovascular parameters via activation of the nuclear factor erythroid 2 (NRF2) and reduction of XOR and nitrated protein levels. Our data suggested that the inhibition of XOR and oxidative stress damage could help prevent the severe cardiovascular injuries of this disorder.Keywords
Funding Information
- Ministerio de Ciencia e Innovación (AEI/MINEICO/FEDER, UE) (SAF2016-78508-R, PID2020-113634RB-C2, 2017-SGR1794)
- Association “Autour des Williams” (SAF2016-78508-R, PID2020-113634RB-C2, 2017-SGR1794)
- Generalitat de Catalunya (SAF2016-78508-R, PID2020-113634RB-C2, 2017-SGR1794)
This publication has 39 references indexed in Scilit:
- Impairment of flow-mediated dilation correlates with aortic dilation in patients with Marfan syndromeHeart and Vessels, 2013
- Reduction of NADPH-Oxidase Activity Ameliorates the Cardiovascular Phenotype in a Mouse Model of Williams-Beuren SyndromePLOS Genetics, 2012
- Calcium Channel BlockersThe Journal of Clinical Hypertension, 2011
- Williams–Beuren SyndromeNew England Journal of Medicine, 2010
- Curcumin improves wound healing by modulating collagen and decreasing reactive oxygen speciesMolecular and Cellular Biochemistry, 2006
- Hemizygosity at the NCF1 Gene in Patients with Williams-Beuren Syndrome Decreases Their Risk of HypertensionThe American Journal of Human Genetics, 2006
- Allopurinol Attenuates Left Ventricular Remodeling and Dysfunction After Experimental Myocardial InfarctionCirculation, 2004
- Risk of sudden death in the Williams–Beuren syndromeAmerican Journal of Medical Genetics Part A, 2004
- Xanthine Oxidase Reaction with Nitric Oxide and PeroxynitriteArchives of Biochemistry and Biophysics, 1998
- Cardiovascular effects of verapamil in patients with essential hypertension.Circulation, 1987